Search

everythinglearnresearchcommunity

for

Search:↓

The book is a useful guide for dermatologists studying for their board exam, with clinical images and features of skin diseases.

Infliximab can trigger lupus-like symptoms in Crohn's disease patients.

Patients with acute and subacute skin lupus respond faster to belimumab than those with chronic skin lupus.

A young woman with lupus was treated with hydroxychloroquine and prednisone.

Enteric hyperoxaluria can cause severe kidney failure after bowel surgery.

A patient with lupus experienced complete hair regrowth after treatment with thalidomide.

High-dose corticosteroid treatment helped improve symptoms in a patient with Adult Onset Still Disease.

Two children with lysinuric protein intolerance showed symptoms similar to lupus.

Older adults diagnosed with lupus show less severe symptoms but have a lower survival rate, often due to age-related factors.

CD18-deficient mice developed psoriasis-like skin disease, useful for studying inflammatory skin disorders.

The document concludes that Telogen Effluvium is a hair loss disorder that can be assessed with the modified wash test and may be treated with clobetasol foam, with patient management being important.

Skin reactions from cancer treatments might predict how well the treatments work.

Treating H. pylori infection might help cure alopecia areata.

Some COVID-19 patients lose hair, with the most common type linked to male hormones and possibly increasing the risk of severe illness.

Carbamazepine may cause lung problems and lupus-like symptoms, which can improve after stopping the drug.

Volatile organic compounds can cause inflammation and increase the risk of autoimmune diseases.

Generic drug inserts in Saudi Arabia often have inaccurate information, needing better regulation and quality control.

Patients with RASopathies are at risk for autoimmune disorders and should be routinely screened.

Synthetic antioxidants are effective, cheap, and stable, with some like zinc and cholecalciferol reducing child and cancer deaths, but the safety of additives like BHA, BHT, TBHQ, and PEG needs more research.

NIH dermatology funding increased by 14.7% from 2015 to 2019, but men and certain states and institutions received most of the money.

Some skin medications can have harmful interactions with the COVID-19 drug nirmatrelvir-ritonavir, but not with molnupiravir.

White blood cells and their traps can slow down the process of new hair growth after a wound.

The study created 3D-printed pills that effectively release a hair loss treatment drug over 24 hours.

People on immune-modifying skin disease treatments may have a weaker antibody response to COVID-19 vaccines but often improve after the second dose.

Iron deficiency anemia may contribute to hair loss in women with Telogen effluvium.

Finasteride may be linked to Peyronie’s disease, but more research is needed.

Lack of sleep in mice leads to prostatitis by reducing certain hormones and activating an inflammatory pathway, which can be temporarily fixed with normal sleep.

Nanomaterials can significantly improve wound healing and future treatments may include smart, real-time monitoring.

Non-scarring hair loss is common in lupus patients and can be diagnosed with specific hair and tissue tests.

Some medications might contribute to male infertility, with finasteride showing a high number of reports.